Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose

Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose - Biological E, Hyderabad-based pharmaceutical company on Tuesday received the emergency-use authorisation for manufacturing and marketing of Corbevax.

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,Bharat , ,Expert Committee ,Drug Controller General ,Bharat Biotech ,Biologicale Corbevax ,Phase 3 ,Clinical Trials ,Drug Controller General Of India Dcgi ,Orbevax ,Booster Dose ,Bharat Biotech Covaxin ,Ovaxin Booster Shot ,